1417 POSTER A Phase II Trial of Afatinib (BIBW 2992) in Patients With Tumours Prospectively Screened for EGFR And/or HER2 Gene Amplification or EGFR Activating Mutations von Kwak, E.L, Shapiro, G.I, Cohen, S.M, Becerra, C.R, Lenz, H.J, Gooden, S, Robohn, M, Le-Maulf, F, Chand, V.K, lafrate, A.J

Volltext

Crizotinib in advanced ROS1-rearranged non-small cell lung cancer (NSCLC): updated results from PROFILE 1001 von Shaw, A., Riley, G.J., Bang, Y.-J., Kim, D.-W., Camidge, D.R., Varella-Garcia, M., Lafrate, A.J., Shapiro, G., Winter, M., Usari, T., Wang, S.C., Wilner, K., Clark, J.W., Ou, S.-H.I.

Volltext

Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice von Sequist, L.V., Heist, R.S., Shaw, A.T., Fidias, P., Rosovsky, R., Temel, J.S., Lennes, I.T., Digumarthy, S., Waltman, B.A., Bast, E., Tammireddy, S., Morrissey, L., Muzikansky, A., Goldberg, S.B., Gainor, J., Channick, C.L., Wain, J.C., Gaissert, H., Donahue, D.M., Muniappan, A., Wright, C., Willers, H., Mathisen, D.J., Choi, N.C., Baselga, J., Lynch, T.J., Ellisen, L.W., Mino-Kenudson, M., Lanuti, M., Borger, D.R., Iafrate, A.J., Engelman, J.A., Dias-Santagata, D.

Volltext